Dermatology in Washington, MO
3 verified dermatology doctors in Washington.
Dermatologists treat conditions of the skin, hair, and nails, from acne and eczema to skin cancer screening.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Missouri Board of Registration for the Healing Arts
Dr. Jason Reinberg, MD
Dermatology
CMS Open Payments· $941.75 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$941.75
Total received
50
Transactions
18
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 73th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Jason Reinberg do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Elizabeth Vanderah, MD
Dermatology
CMS Open Payments· $350.95 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$350.95
Total received
17
Transactions
9
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 60th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Elizabeth Vanderah do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Brad Rumancik, MD
Dermatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.